| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.53 | 0.0007 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.49 | 0.008 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |